Managing Patients with Psoriatic Disease: The Diagnosis and Pharmacologic Treatment of Psoriatic Arthritis in Patients with Psoriasis
Open accessThe DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Abstract
Psoriatic arthritis (PsA) is a chronic, systemic inflammatory disease. Up to 40 % of patients with psoriasis will go on to develop PsA, usually within 5-10 years of cutaneous disease onset. Both conditions share common pathogenic mechanisms involving genetic and environmental factors. Because psoriasis is typically present for years before PsA-related joint symptoms emerge, dermatologists are in a unique position to detect PsA earlier in the disease process through regular, routine screening of psoriasis patients. Distinguishing clinical features of PsA include co-occurrence of psoriatic skin lesions and nail dystrophy, as well as dactylitis and enthesitis. Patients with PsA are usually seronegative for rheumatoid factor, and radiographs may reveal unique features such as juxta-articular new bone formation and pencil-in-cup deformity. Early treatment of PsA with disease-modifying anti-rheumatic drugs has the potential to slow disease progression and maintain patient quality of life. Optimally, a single therapeutic agent will control both the skin and joint psoriatic symptoms. A number of traditional treatments used to manage psoriasis, such as methotrexate and cyclosporine, are also effective for PsA, but these agents are often inadequately effective, temporary in benefit and associated with significant safety concerns. Biologic anti-tumour necrosis factor agents, such as etanercept, infliximab and adalimumab, are effective for treating patients who have both psoriasis and PsA. However, a substantial number of patients may lose efficacy, have adverse effects or find intravenous or subcutaneous administration inconvenient. Emerging oral treatments, including phosphodiesterase 4 inhibitors, such as apremilast, and new biologics targeting interleukin-17, such as secukinumab, brodalumab and ixekizumab, have shown encouraging clinical results in the treatment of psoriasis and/or PsA. Active and regular collaboration of dermatologists with rheumatologists in managing patients who have psoriasis and PsA is likely to yield more optimal control of psoriatic dermal and joint symptoms, and improve long-term patient outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Taylor, W., Gladman, D., Helliwell, P., Marchesoni, A., Mease, P., & Mielants, H. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21972 · Cited by 3,746
Self-citationNestle, F. O., Kaplan, D. H., & Barker, J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804595 · Cited by 2,786
Leonardi, C. L., Kimball, A. B., Papp, K. A., Yeilding, N., Guzzo, C., Wang, Y., Li, S., Dooley, L. T., & Gordon, K. B. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60725-4 · Cited by 1,874
Psoriatic arthritis: epidemiology, clinical features, course, and outcome
Gladman, D. D., Antoni, C., Mease, P., Clegg, D. O., & Nash, P. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.032482 · Cited by 1,536
Self-citationPsoriasis causes as much disability as other major medical diseases
Rapp, S. R., Feldman, S. R., Exum, M. L., Fleischer, A. B., & Reboussin, D. M. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70112-x · Cited by 1,491
Moll, J. M. H., & Wright, V. (1973) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(73)90035-8 · Cited by 1,261
Guidelines of care for the management of psoriasis and psoriatic arthritis
Menter, A., Gottlieb, A., Feldman, S. R., Van Voorhees, A. S., Leonardi, C. L., Gordon, K. B., Lebwohl, M., Koo, J. Y. M., Elmets, C. A., Korman, N. J., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.02.039 · Cited by 1,222
Etanercept as Monotherapy in Patients with Psoriasis
Leonardi, C. L., Powers, J. L., Matheson, R. T., Goffe, B. S., Zitnik, R., Wang, A., & Gottlieb, A. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030409 · Cited by 1,175
Tyring, S., Gottlieb, A., Papp, K., Gordon, K., Leonardi, C., Wang, A., Lalla, D., Woolley, M., Jahreis, A., Zitnik, R., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(05)67763-x · Cited by 1,069 · cited 1×
“PsA, including inhibition of radiographic progression [2, 118–121, 126, 136, 153–155].”
BackgroundReich, K., Nestle, F. O., Papp, K., Ortonne, J.-P., Evans, R., Guzzo, C., Li, S., Dooley, L. T., & Griffiths, C. E. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67566-6 · Cited by 1,045
Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
Fleischmann, R., Kremer, J., Cush, J., Schulze-Koops, H., Connell, C. A., Bradley, J. D., Gruben, D., Wallenstein, G. V., Zwillich, S. H., & Kanik, K. S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109071 · Cited by 1,024
Homeostasis and Self-Tolerance in the Immune System: Turning Lymphocytes off
Parijs, L. V., & Abbas, A. K. (1998) · Science · doi:10.1126/science.280.5361.243 · Cited by 965
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
van Vollenhoven, R. F., Fleischmann, R., Cohen, S., Lee, E. B., García Meijide, J. A., Wagner, S., Forejtova, S., Zwillich, S. H., Gruben, D., Koncz, T., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112072 · Cited by 945
Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
Papp, K. A., Leonardi, C., Menter, A., Ortonne, J.-P., Krueger, J. G., Kricorian, G., Aras, G., Li, J., Russell, C. B., Thompson, E. H. Z., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109017 · Cited by 941
Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
Leonardi, C., Matheson, R., Zachariae, C., Cameron, G., Li, L., Edson-Heredia, E., Braun, D., & Banerjee, S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109997 · Cited by 936
Mease, P. J., Gladman, D. D., Ritchlin, C. T., Ruderman, E. M., Steinfeld, S. D., Choy, E. H. S., Sharp, J. T., Ory, P. A., Perdok, R. J., & Weinberg, M. A. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21306 · Cited by 909
Self-citationEtanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression
Mease, P. J., Kivitz, A. J., Burch, F. X., Siegel, E. L., Cohen, S. B., Ory, P., Salonen, D., Rubenstein, J., Sharp, J. T., & Tsuji, W. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20335 · Cited by 882
Self-citationComparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
Griffiths, C. E. M., Strober, B. E., van de Kerkhof, P., Ho, V., Fidelus-Gort, R., Yeilding, N., Guzzo, C., Xia, Y., Zhou, B., Li, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0810652 · Cited by 859
Mechanisms of action of cyclosporine
Matsuda, S., & Koyasu, S. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)00192-2 · Cited by 812
Saurat, J. ‐., Stingl, G., Dubertret, L., Papp, K. A., Langley, R. G. B., Ortonne, J. ‐., Unnebrink, K., Kaul, M., Camez, A., & for the CHAMPION Study Investigators (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08315.x · Cited by 798
Guidelines of care for the management of psoriasis and psoriatic arthritis
Gottlieb, A., Korman, N. J., Gordon, K. B., Feldman, S. R., Lebwohl, M., Koo, J. Y. M., Van Voorhees, A. S., Elmets, C. A., Leonardi, C. L., Beutner, K. R., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.02.040 · Cited by 769
Stern, R. S., Nijsten, T., Feldman, S. R., Margolis, D. J., & Rolstad, T. (2004) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.1087-0024.2003.09102.x · Cited by 732
Papp, K., Reich, K., Leonardi, C. L., Kircik, L., Chimenti, S., Langley, R. G. B., Hu, C., Stevens, R. M., Day, R. M., Gordon, K. B., et al. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.03.049 · Cited by 678
Antoni, C. E., Kavanaugh, A., Kirkham, B., Tutuncu, Z., Burmester, G. R., Schneider, U., Furst, D. E., Molitor, J., Keystone, E., Gladman, D., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20967 · Cited by 640
Keynote review: Phosphodiesterase-4 as a therapeutic target
Houslay, M. D., Schafer, P., & Zhang, K. Y. J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03622-6 · Cited by 635
Ritchlin, C. T., Haas-Smith, S. A., Li, P., Hicks, D. G., & Schwarz, E. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16069 · Cited by 616
Wilson, F. C., Icen, M., Crowson, C. S., McEvoy, M. T., Gabriel, S. E., & Kremers, H. M. (2009) · Arthritis Care & Research · doi:10.1002/art.24172 · Cited by 605
Kavanaugh, A., McInnes, I., Mease, P., Krueger, G. G., Gladman, D., Gomez‐Reino, J., Papp, K., Zrubek, J., Mudivarthy, S., Mack, M., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24403 · Cited by 602
Self-citationGottlieb, A., Menter, A., Mendelsohn, A., Shen, Y.-K., Li, S., Guzzo, C., Fretzin, S., Kunynetz, R., & Kavanaugh, A. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60140-9 · Cited by 585
The Psychosocial Burden of Psoriasis
Kimball, A. B., Jacobson, C., Weiss, S., Vreeland, M. G., & Wu, Y. (2005) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200506060-00005 · Cited by 558
Guidelines of care for the management of psoriasis and psoriatic arthritis
Menter, A., Korman, N. J., Elmets, C. A., Feldman, S. R., Gelfand, J. M., Gordon, K. B., Gottlieb, A. B., Koo, J. Y. M., Lebwohl, M., Lim, H. W., et al. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.03.027 · Cited by 558
Treatment recommendations for psoriatic arthritis
Ritchlin, C. T., Kavanaugh, A., Gladman, D. D., Mease, P. J., Helliwell, P., Boehncke, W.-H., de Vlam, K., Fiorentino, D., FitzGerald, O., Gottlieb, A. B., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.094946 · Cited by 554
Self-citationKurd, S. K., & Gelfand, J. M. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.09.022 · Cited by 519
Austin, L. M., Ozawa, M., Kikuchi, T., Walters, I. B., & Krueger, J. G. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00749.x · Cited by 485
Leflunomide: mode of action in the treatment of rheumatoid arthritis
Breedveld, F. C., & Dayer, J.-M. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.11.841 · Cited by 485
Shamji, M. F., Setton, L. A., Jarvis, W., So, S., Chen, J., Jing, L., Bullock, R., Isaacs, R. E., Brown, C., & Richardson, W. J. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27444 · Cited by 469
Guidelines of care for the management of psoriasis and psoriatic arthritis
Menter, A., Korman, N. J., Elmets, C. A., Feldman, S. R., Gelfand, J. M., Gordon, K. B., Gottlieb, A., Koo, J. Y. M., Lebwohl, M., Leonardi, C. L., et al. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.11.055 · Cited by 460
Psoriasis and metabolic syndrome: A systematic review and meta-analysis of observational studies
Armstrong, A. W., Harskamp, C. T., & Armstrong, E. J. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.08.015 · Cited by 459
Self-citationLowes, M. A., Chamian, F., Abello, M. V., Fuentes-Duculan, J., Lin, S.-L., Nussbaum, R., Novitskaya, I., Carbonaro, H., Cardinale, I., Kikuchi, T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509736102 · Cited by 456
Piskin, G., Sylva-Steenland, R. M. R., Bos, J. D., & Teunissen, M. B. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1908 · Cited by 454
Uyemura, K., Yamamura, M., Fivenson, D. F., Modlin, R. L., & Nickoloff, B. J. (1993) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12371679 · Cited by 450
Clegg, D. O., Reda, D. J., Mejias, E., Cannon, G. W., Weisman, M. H., Taylor, T., Budiman‐Mak, E., Blackburn, W. D., Vasey, F. B., Mahowald, M. L., et al. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391210 · Cited by 447
Gossec, L., Smolen, J. S., Gaujoux-Viala, C., Ash, Z., Marzo-Ortega, H., van der Heijde, D., FitzGerald, O., Aletaha, D., Balint, P., Boumpas, D., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200350 · Cited by 446
Zaba, L. C., Fuentes-Duculan, J., Eungdamrong, N. J., Abello, M. V., Novitskaya, I., Pierson, K. C., Gonzalez, J., Krueger, J. G., & Lowes, M. A. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.194 · Cited by 442
Cyclosporine for Plaque-Type Psoriasis: Results of a Multidose, Double-Blind Trial
Ellis, C. N., Fradin, M. S., Messana, J. M., Brown, M. D., Siegel, M. T., Hartley, A. H., Rocher, L. L., Wheeler, S., Hamilton, T. A., Parish, T. G., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101313240501 · Cited by 429
Cyclic AMP: Master Regulator of Innate Immune Cell Function
Serezani, C. H., Ballinger, M. N., Aronoff, D. M., & Peters-Golden, M. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0091tr · Cited by 415
Kaltwasser, J. P., Nash, P., Gladman, D., Rosen, C. F., Behrens, F., Jones, P., Wollenhaupt, J., Falk, F. G., & Mease, P. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20253 · Cited by 413
Self-citationSchafer, P., Parton, A., Gandhi, A., Capone, L., Adams, M., Wu, L., Bartlett, J., Loveland, M., Gilhar, A., Cheung, Y., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00559.x · Cited by 406
Fleischmann, R., Cutolo, M., Genovese, M. C., Lee, E. B., Kanik, K. S., Sadis, S., Connell, C. A., Gruben, D., Krishnaswami, S., Wallenstein, G., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33383 · Cited by 376
Salaffi, F., Carotti, M., Gasparini, S., Intorcia, M., & Grassi, W. (2009) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-7-25 · Cited by 371
Papp, K. A., Langley, R. G., Sigurgeirsson, B., Abe, M., Baker, D. R., Konno, P., Haemmerle, S., Thurston, H. J., Papavassilis, C., & Richards, H. B. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12110 · Cited by 360
Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin
Johansen, C., Usher, P. A., Kjellerup, R. B., Lundsgaard, D., Iversen, L., & Kragballe, K. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08902.x · Cited by 352
McInnes, I. B., Sieper, J., Braun, J., Emery, P., van der Heijde, D., Isaacs, J. D., Dahmen, G., Wollenhaupt, J., Schulze-Koops, H., Kogan, J., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202646 · Cited by 343
Psoriasis and the Risk of Diabetes Mellitus: A Systematic Review and Meta-analysis
Armstrong, A. W., Harskamp, C. T., & Armstrong, E. J. (2013) · JAMA Dermatology · doi:10.1001/2013.jamadermatol.406 · Cited by 342 · cited 1×
“Patients with psoriasis, PsA or both generally have reduced health-related quality of life (QOL), productivity and functionality similar to those of patients with other serious diseases, such as cancer, heart disease and diabetes [20–30].”
BackgroundSelf-citationMease, P. J. (2011) · Arthritis Care & Research · doi:10.1002/acr.20577 · Cited by 342
Self-citationPapp, K. A., Menter, A., Strober, B., Langley, R. G., Buonanno, M., Wolk, R., Gupta, P., Krishnaswami, S., Tan, H., & Harness, J. A. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11168.x · Cited by 338
Co-morbidity and Age-related Prevalence of Psoriasis: Analysis of Health Insurance Data in Germany
Augustin, M., Reich, K., Glaeske, G., Schaefer, I., & Radtke, M. (2010) · Acta Dermato Venereologica · doi:10.2340/00015555-0770 · Cited by 337
Chromosomal Translocations in Ewing's Sarcoma
(1983) · New England Journal of Medicine · doi:10.1056/nejm198308253090817 · Cited by 330
A randomized placebo-controlled trial of methotrexate in psoriatic arthritis
Kingsley, G. H., Kowalczyk, A., Taylor, H., Ibrahim, F., Packham, J. C., McHugh, N. J., Mulherin, D. M., Kitas, G. D., Chakravarty, K., Tom, B. D. M., et al. (2012) · Rheumatology · doi:10.1093/rheumatology/kes001 · Cited by 322
Familial occurrence of psoriatic arthritis.
Moll, J. M., & Wright, V (1973) · Annals of the Rheumatic Diseases · doi:10.1136/ard.32.3.181 · Cited by 300
Willkens, R. F., Williams, H. J., Ward, J. R., Egger, M. J., Reading, J. C., Clements, P. J., Cathcart, E. S., Samuelson, C. O., Solsky, M. A., Kaplan, S. B., et al. (1984) · Arthritis & Rheumatism · doi:10.1002/art.1780270403 · Cited by 289
Papp, K., Cather, J. C., Rosoph, L., Sofen, H., Langley, R. G., Matheson, R. T., Hu, C., & Day, R. M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60642-4 · Cited by 282
Dactylitis in psoriatic arthritis: a marker for disease severity?
Brockbank, J. E., Stein, M., Schentag, C. T., & Gladman, D. D. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.018184 · Cited by 268
Ash, Z., Gaujoux-Viala, C., Gossec, L., Hensor, E. M., FitzGerald, O., Winthrop, K., van der Heijde, D., Emery, P., Smolen, J. S., & Marzo-Ortega, H. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.150995 · Cited by 258
Gniadecki, R., Kragballe, K., Dam, T. N., & Skov, L. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10213.x · Cited by 248
Rich, P., Sigurgeirsson, B., Thaçi, D., Ortonne, J. ‐., Paul, C. F., Schopf, R. E., Morita, A., Roseau, K., Harfst, E., Guettner, A., et al. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12112 · Cited by 244
Lundberg, M. J. (2000) · Acta Dermato-Venereologica · doi:10.1080/000155500300012873 · Cited by 233
HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype
Winchester, R., Minevich, G., Steshenko, V., Kirby, B., Kane, D., Greenberg, D. A., & FitzGerald, O. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33415 · Cited by 230
Schett, G., Wollenhaupt, J., Papp, K., Joos, R., Rodrigues, J. F., Vessey, A. R., Hu, C., Stevens, R., & de Vlam, K. L. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34627 · Cited by 205
IL-17 receptor and its functional significance in psoriatic arthritis
Raychaudhuri, S. P., Raychaudhuri, S. K., & Genovese, M. C. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1036-6 · Cited by 203
A 52-Week Trial Comparing Briakinumab with Methotrexate in Patients with Psoriasis
Reich, K., Langley, R. G., Papp, K. A., Ortonne, J.-P., Unnebrink, K., Kaul, M., & Valdes, J. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010858 · Cited by 198
Imagama, S., Matsuyama, Y., Yukawa, Y., Kawakami, N., Kamiya, M., Kanemura, T., Ishiguro, N., Imagama, Ñ. S., & Matsuyama, N. (2010) · Cited by 189
Rich, P., Sigurgeirsson, B., Thaci, D. P., Ortonne, J.-P., Paul, C., Schopf, R. E., Morita, A., Roseau, K., Harfst, E., Guettner, A., et al. (2012) · British Journal of Dermatology · doi:10.1111/bjd.12070 · Cited by 189
Immunity at the surface: Homeostatic mechanisms of the skin immune system
Williams, I. R., & Kupper, T. S. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00042-2 · Cited by 181
Predictors for radiological damage in psoriatic arthritis: results from a single centre
Bond, S. J., Farewell, V. T., Schentag, C. T., & Gladman, D. D. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.056457 · Cited by 178
Chandran, V., Cook, R. J., Edwin, J., Shen, H., Pellett, F. J., Shanmugarajah, S., Rosen, C. F., & Gladman, D. D. (2010) · Rheumatology · doi:10.1093/rheumatology/keq105 · Cited by 175
CARD15: a Pleiotropic Autoimmune Gene That Confers Susceptibility to Psoriatic Arthritis
Rahman, P., Bartlett, S., Siannis, F., Pellett, F. J., Farewell, V. T., Peddle, L., Schentag, C. T., Alderdice, C. A., Hamilton, S., Khraishi, M., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/378076 · Cited by 164
The PKC inhibitor AEB071 may be a therapeutic option for psoriasis
Skvara, H., Dawid, M., Kleyn, E., Wolff, B., Meingassner, J. G., Knight, H., Dumortier, T., Kopp, T., Fallahi, N., Stary, G., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35636 · Cited by 163
Baumer, W., Hoppmann, J., Rundfeldt, C., & Kietzmann, M. (2007) · Inflammation & Allergy-Drug Targets · doi:10.2174/187152807780077318 · Cited by 162
Flytström, I., Stenberg, B., Svensson, Å., & Bergbrant, I.-M. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08284.x · Cited by 160
Reich, K., Ortonne, J.-P., Gottlieb, A. B., Terpstra, I. J., Coteur, G., Tasset, C., & Mease, P. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.10941.x · Cited by 158
Self-citationMease, P. J., Gladman, D. D., & Keystone, E. C. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21870 · Cited by 158
Self-citationBurden of Disease: Psoriasis and Psoriatic Arthritis
Boehncke, W., & Menter, A. (2013) · American Journal of Clinical Dermatology · doi:10.1007/s40257-013-0032-x · Cited by 151
Tinazzi, I., Adámi, S., Zanolin, E. M., Caimmi, C., Confente, S., Girolomoni, G., Gisondi, P., Biasi, D., & McGonagle, D. (2012) · Rheumatology · doi:10.1093/rheumatology/kes187 · Cited by 150
Boy, M. G., Wang, C., Wilkinson, B. E., Chow, V. F.-S., Clucas, A., Krueger, J. G., Gaweco, A. S., Zwillich, S. H., Changelian, P. S., & Chan, G. L. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.25 · Cited by 142
Investigation of association of the IL12B and IL23R genes with psoriatic arthritis
Filer, C., Ho, P., Smith, R. L., Griffiths, C., Young, H. S., Worthington, J., Bruce, I. N., & Barton, A. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24128 · Cited by 140
Hüffmeier, U., Lascorz, J., Böhm, B. B., Lohmann, J., Wendler, J., Mößner, R., Reich, K., Traupe, H., Kurrat, W., Burkhardt, H., et al. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.233 · Cited by 134
Genome-Wide Meta-Analysis of Psoriatic Arthritis Identifies Susceptibility Locus at REL
Ellinghaus, E., Stuart, P. E., Ellinghaus, D., Nair, R. P., Debrus, S., Raelson, J., Belouchi, M., Tejasvi, T., Li, Y., Tsoi, L. C., et al. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.415 · Cited by 133
Batliwalla, F., Li, W., Ritchlin, C. T., Xiao, X., Brenner, M., Laragione, T., Shao, T., Durham, R. A., Kemshetti, S., Schwarz, E. M., et al. (2005) · Molecular Medicine · doi:10.2119/2006-00003.gulko · Cited by 126
Harnessing dendritic cells in inflammatory skin diseases
Chu, C.-C., Meglio, P. D., & Nestle, F. O. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.01.006 · Cited by 125
Sulfasalazine therapy for psoriatic arthritis: a double blind, placebo controlled trial.
Gupta, A. K., Grober, J. S., HAMILTON, T. A., Ellis, C. N., Siegel, M. T., Voorhees, J. J., & McCune, W. J. (1995) · PubMed · Cited by 118
Yawalkar, N., Tscharner, G. G., Hunger, R. E., & Hassan, A. S. (2009) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2009.01.003 · Cited by 115
Dalbeth, N., Pool, B., Smith, T., Callon, K. E., Lobo, M., Taylor, W. J., Jones, P. B., Cornish, J., & McQueen, F. M. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3123 · Cited by 115
Psoriasis: an epidemiological evaluation of disease burden in 590 patients
Meyer, N., Paul, C. F., Feneron, D., Bardoulat, I., Thiriet, C., Camara, C., Sid-Mohand, D., Pen, C. L., & Ortonne, J. ‐. (2010) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2010.03600.x · Cited by 111
Spondyloarthritis Is Associated with Poor Function and Physical Health-Related Quality of Life
Singh, J. A., & Strand, V. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.081015 · Cited by 111
Identification of the Clinical Features Distinguishing Psoriatic Arthritis and Fibromyalgia
Marchesoni, A., Atzeni, F., Spadaro, A., Lubrano, E., Provenzano, G., Cauli, A., Olivieri, I., Melchiorre, D., Salvarani, C., Scarpa, R., et al. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.110893 · Cited by 110
Zaba, L. C., Fuentes‐Duculan, J., Eungdamrong, N. J., Johnson-Huang, L. M., Nograles, K. E., White, T. R., Pierson, K. C., Lentini, T., Suárez‐Fariñas, M., Lowes, M. A., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.03.018 · Cited by 106
David, M., Akerman, L., Ziv, M., Kadurina, M., Gospodinov, D. K., Pavlotsky, F., Yankova, R. K., Kouzeva, V., Ramon, M., Silverman, M. H., et al. (2011) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2011.04078.x · Cited by 102
Papp, K. A., Bissonnette, R., Rosoph, L. A., Wasel, N. R., Lynde, C. W., Searles, G. E., Shear, N., Huizinga, R. B., & Maksymowych, W. P. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60593-0 · Cited by 95
Nielsen, O. H., Bukhave, K., Elmgreen, J., & Ahnfelt-Rønne, I. (1987) · Digestive Diseases and Sciences · doi:10.1007/bf01296156 · Cited by 94
Clinical characteristics of psoriatic arthritis and psoriasis in dermatologists' offices
Gottlieb, A. B., Mease, P. J., Jackson, J. M., Eisen, D., Xia, H. A., Asare, C., & Stevens, S. R. (2006) · Journal of Dermatological Treatment · doi:10.1080/09546630600823369 · Cited by 85
Self-citationTNFα polymorphisms and risk of psoriatic arthritis
Rahman, P., Siannis, F., Butt, C., Farewell, V. T., Peddle, L., Pellett, F., & Gladman, D. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.039164 · Cited by 85
Ravindran, V. K., Scott, D. L., & Choy, E. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.072652 · Cited by 80
Sulfasalazine improves psoriasis. A double-blind analysis
Gupta, A. K. (1990) · Archives of Dermatology · doi:10.1001/archderm.126.4.487 · Cited by 77
Psoriasis and psoriatic arthritis: separate or one and the same?
Ciocon, D. H., & Kimball, A. B. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08148.x · Cited by 69
Nash, P. T., Thaçi, D., Behrens, F., Falk, F., & Kaltwasser, J. P. (2006) · Dermatology · doi:10.1159/000091251 · Cited by 68
Gout: epitome of painful arthritis
VanItallie, T. B. (2010) · Metabolism · doi:10.1016/j.metabol.2010.07.009 · Cited by 68
Henno, A., Blacher, S., Lambert, C. A., Deroanne, C., Noël, A., Lapiere, C. M., Brassinne, M. D. L., Nusgens, B., & Colige, A. (2010) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2009.12.006 · Cited by 60
Management of psoriatic arthritis from the view of the dermatologist
Chang, C. A., Gottlieb, A. B., & Lizzul, P. F. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.125 · Cited by 57
Chan, B., Hales, B. M., Shear, N. H., HO, V. C., Lynde, C. W., Poulin, Y. P., & Mittmann, N. (2009) · Journal of Cutaneous Medicine and Surgery · doi:10.2310/7750.2009.08068 · Cited by 57
Sulfasalazine Improves Psoriasis: A Double-blind Analysis
Gupta, A. K. (1990) · Archives of Dermatology · doi:10.1001/archderm.1990.01670280071013 · Cited by 54
Häuser, W., Hayo, S., Biewer, W., Gesmann, M., Kühn-Becker, H., Petzke, F. W., von Wilmoswky, H., & Langhorst, J. (2010) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e3181d92a6c · Cited by 54
The ACCEPT study: ustekinumab versus etanercept in moderate-to-severe psoriasis patients
Young, M. S., Horn, E. J., & Cather, J. C. (2010) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.92 · Cited by 51
Long-term efficacy of biologics in the treatment of psoriasis: what do we really know?
Alwawi, E. A., Krulig, E., & Gordon, K. B. (2009) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2009.01259.x · Cited by 42
Identification of interleukin‐7 as a candidate disease mediator in spondylarthritis
Rihl, M., Kellner, H. L., Kellner, W., Barthel, C., Yu, D. T. Y., Tak, P. P., Zeidler, H. K., & Baeten, D. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23998 · Cited by 40
Psoriatic arthritis and psoriasis: Need for a multidisciplinary approach
Qureshi, A. A., Husni, M. E., & Mody, E. (2005) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/j.sder.2005.01.006 · Cited by 32
Do TNF Inhibitors Reduce the Risk of Myocardial Infarction in Psoriasis Patients?
Armstrong, A. W. (2013) · JAMA · doi:10.1001/jama.2013.4695 · Cited by 30
Self-citationRahman, P., Roslin, N. M., Pellett, F., Lemire, M., Greenwood, C. M. T., Beyene, J., Pope, A. N., Peddle, L., Paterson, A. D., Uddin, M. J., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.133561 · Cited by 26
Genetic susceptibility factors for psoriatic arthritis
Castelino, M., & Barton, A. C. (2010) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32833669d2 · Cited by 22
Review of Clinical Registries of Psoriatic Arthritis: Lessons Learned? Value for the Future?
Gladman, D. D., & Chandran, V. (2011) · Current Rheumatology Reports · doi:10.1007/s11926-011-0182-x · Cited by 15
Cited by
Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
Mease, P. J., McInnes, I. B., Kirkham, B., Kavanaugh, A., Rahman, P., van der Heijde, D., Landewé, R., Nash, P., Pricop, L., Yuan, J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1412679 · Cited by 746
Self-citationFitzGerald, O., Ogdie, A., Chandran, V., Coates, L. C., Kavanaugh, A., Tillett, W., Leung, Y. Y., deWit, M., Scher, J. U., & Mease, P. J. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00293-y · Cited by 367
Self-citationInterleukin-17 and innate immunity in infections and chronic inflammation
Isailovic, N., Daigo, K., Mantovani, A., & Selmi, C. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.04.006 · Cited by 363
Villani, A. P., Rouzaud, M., Sevrain, M., Barnetche, T., Paul, C., Richard, M.-A., Beylot-Barry, M., Misery, L., Joly, P., Le Maitre, M., et al. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.05.001 · Cited by 300
McGonagle, D. G., McInnes, I. B., Kirkham, B. W., Sherlock, J., & Moots, R. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215356 · Cited by 254
Metadata
- Authors
- Mease, P. J., & Armstrong, A. W.
- Venue
- Drugs
- Published
- 2014-02-25
- Volume
- 74
- Issue
- 4
- Pages
- 423-441
- ISSN
- 0012-6667 (ISSN-L)
- 1179-1950
- OpenAlex
- W2083707884
- Cited by
- 271
- References
- 120
- Type
- book review
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.